Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motor.

Long Zhang, Nicolas Burns, Zhouxiang Ji, Steven Sun, Susan L Deutscher, William E Carson, Peixuan Guo

Nanomedicine : nanotechnology, biology, and medicine 2023 Feb

filter terms:

Detection of cancer in its early stage is a challenging task for oncologists. Inflammatory breast cancer has symptoms that are similar to mastitis and can be mistaken for microbial infection. Currently, the differential diagnosis between mastitis and Inflammatory breast cancer via nipple aspirate fluid (NAF) is difficult. Here, we report a label-free and amplification-free detection platform using an engineered nanopore of the phi29 DNA-packaging motor with biomarker Galectin3 (GAL3), Thomsen-Friedenreich (TF) binding peptide as the probe fused at its C-terminus. The binding of the biomarker in NAF samples from breast cancer patients to the probe results in the connector's conformational change with a current blockage of 32 %. Utilization of dwell time, blockage ratio, and peak signature enable us to detect basal levels of biomarkers from patient NAF samples at the single-molecule level. This platform will allow for breast cancers to be resolved at an early stage with accuracy and thoroughness. Published by Elsevier Inc.

Citation

Long Zhang, Nicolas Burns, Zhouxiang Ji, Steven Sun, Susan L Deutscher, William E Carson, Peixuan Guo. Nipple fluid for breast cancer diagnosis using the nanopore of Phi29 DNA-packaging motor. Nanomedicine : nanotechnology, biology, and medicine. 2023 Feb;48:102642